Kneat.com Inc. (KSI)
TSX
Closed
Aug 13, 2026
Day's Range
6.5052 wk Range
3.23Overview - KSI - Kneat.com Inc.
Key Statistics
Valuation
Enterprise Value
600.10M
P/E (Trailing)
‪430.00‬
P/E (Forward)
‪260.00‬
PEG Ratio
‪-1.43‬
Price / Sales (TTM)
‪9.43‬
Price / Book
‪9.90‬
EV / EBITDA
‪-65.32‬
Profitability
Gross Margin
‪77.52%‬
Profit Margin
‪-12.68%‬
Operating Margin
‪-12.93%‬
Return on Assets
‪-4.25%‬
Return on Equity
‪-12.98%‬
Ownership
Shares Outstanding
96.13M
Float
75.21M
Held by Insiders
‪21.77%‬
Held by Institutions
‪22.59%‬
Price stats
Beta
‪1.32‬
50-Day Avg
‪6.40‬
200-Day Avg
‪4.92‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
2 analysts
Average price target
‪CA$ 6.00‬Market Cap - KSI - Kneat.com Inc.
Peers - KSI - Kneat.com Inc.
Peer Comparison
Compared with companies in Health Information Services listed on TSX.
- KSITSXKneat.com Inc.627.71MMarket Cap+15.85%52-week change430.00P/E (Trailing)‪-12.68%‬Profit Margin
- TXGTSXTorex Gold Resources Inc.6.46BMarket Cap+38.93%52-week change7.77P/E (Trailing)‪32.96%‬Profit Margin
- VHITSXVitalhub Corp.511.14MMarket Cap-62.08%52-week change67.25P/E (Trailing)‪5.88%‬Profit Margin
- AIAITSXNetraMark Holdings Inc.63.08MMarket Cap-40.30%52-week change-9.57P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - KSI - Kneat.com Inc.
About
Kneat.com Inc. is a provider of software solutions specializing in the digital transformation of validation processes. The company's primary function is to offer a modern, efficient platform for managing the complex and regulatory-heavy validation lifecycle within industries such as pharmaceuticals, biotechnology, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
